These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3554776)

  • 21. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of indirect immunofluorescence as a confirmatory assay in the serologic diagnosis of infection by human immunodeficiency virus (HIV)].
    Picchio GR; Muchinik GR
    Medicina (B Aires); 1988; 48(2):120-4. PubMed ID: 3068476
    [No Abstract]   [Full Text] [Related]  

  • 23. Development and evaluation of serological assays for detection of human hantavirus infections caused by Sin Nombre virus.
    Schmidt J; Meisel H; Hjelle B; Krüger DH; Ulrich R
    J Clin Virol; 2005 Jul; 33(3):247-53. PubMed ID: 15911448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of HTLV III screening tests in Christchurch.
    Field D; Whyte G; Robertson S
    N Z Med J; 1985 Nov; 98(791):992-3. PubMed ID: 3001606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low prevalence of human T lymphotropic virus type I in !Kung San in Bushmanland, Namibia.
    Steele AD; Bos P; Joubert JJ; Evans AC; Joseph S; Tucker L; Aspinall S; Lecatsas G
    Am J Trop Med Hyg; 1994 Oct; 51(4):460-5. PubMed ID: 7943573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How sensitive are the commercial assays for anti-HTLV III/LAV?
    Oldham LJ; Moulsdale HJ; Mortimer PP; Tedder RS; Morgan-Capner P
    J Med Virol; 1987 Jan; 21(1):75-9. PubMed ID: 3467026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [False-positive results in the detection of anti-LAV/HTLV-III antibodies by enzyme immunoassay].
    Näher H; Tilgen W; Tilz G; Petzoldt D
    Hautarzt; 1986 Jun; 37(6):338-40. PubMed ID: 3013804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HIV positivity in Thailand: the usefulness of another ELISA test kit and Western blot as confirmatory tests.
    Ubol S; Phanuphak P; Traisupa A
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):5-11. PubMed ID: 3304323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
    Ayisi NK; Aidoo M
    West Afr J Med; 1994; 13(3):164-7. PubMed ID: 7841107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
    Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
    J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus testing: update.
    Hook WC; Fernandes JJ
    J Am Osteopath Assoc; 1992 Apr; 92(4):485-6, 496-8. PubMed ID: 1601691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of an indirect immunofluorescence assay, western blot analysis, and a commercially available ELISA for detection of Ehrlichia canis antibodies in canine sera.
    O'Connor TP; Hanscom JL; Hegarty BC; Groat RG; Breitschwerdt EB
    Am J Vet Res; 2006 Feb; 67(2):206-10. PubMed ID: 16454622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroimmunology of AIDS retrovirus infection. I. Use of immunofluorescence assay to confirm sera with ELISA reactivity.
    Imrie AA; Kehrer S; Smith GW; Penny R; Cooper DA
    Pathology; 1986 Oct; 18(4):438-43. PubMed ID: 3547270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection.
    Ulstrup JC; Skaug K; Figenschau KJ; Orstavik I; Bruun JN; Petersen G
    Lancet; 1986 May; 1(8490):1151-2. PubMed ID: 2871400
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of indirect immunofluorescence and enzyme-linked immunosorbent assay for detection of toxoplasma antibody.
    Teti G; Leonardi MS; Gazzara D
    Boll Soc Ital Biol Sper; 1981 Mar; 57(5):561-7. PubMed ID: 7020722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LAV/HTLV-III antibodies in patients treated with intravenous gammaglobulins.
    Kanoh T; Ohno T; Funakoshi N; Fujii H; Okada T
    Tohoku J Exp Med; 1986 Nov; 150(3):361-2. PubMed ID: 2435020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.